Practice Test Geeks(APHA) American Public Health Association Immunization Certification Practice Test
← All APHA Flashcard Decks

Vaccine Schedules & Recommendations Flashcards

7 cards from real APHA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Vaccine Schedules & Recommendations flashcards as text

  1. What is the recommended minimum age for the first dose of inactivated polio vaccine (IPV)?

    Answer: 2 months

    The first IPV dose is recommended at 2 months of age as part of the routine childhood immunization schedule.

  2. According to ACIP, adults aged 19–26 years should receive HPV vaccine. How does the recommendation differ for adults aged 27–45?

    Answer: Shared clinical decision-making is recommended for adults 27–45

    ACIP recommends shared clinical decision-making for HPV vaccination of adults aged 27–45, as the benefit varies based on prior exposure.

  3. A child received DTaP doses at 2, 4, 6, and 15 months. When is the fifth and final DTaP dose due?

    Answer: 4–6 years

    The fifth DTaP dose is recommended at 4–6 years of age, completing the primary childhood series before school entry.

  4. Which vaccine should NOT be administered to an individual with a severe allergy to eggs if it is an egg-based formulation and the patient has had anaphylaxis to eggs?

    Answer: Egg-based inactivated influenza vaccine without precautions

    Egg-based influenza vaccines may require observation or should be avoided in individuals with a history of anaphylaxis to eggs; recombinant or cell-based options are preferred.

  5. The meningococcal serogroup B (MenB) vaccine is recommended under shared clinical decision-making for which age group?

    Answer: Adolescents and young adults aged 16–23 years

    MenB vaccination under shared clinical decision-making is recommended for persons aged 16–23 years, with 16–18 years being the preferred window.

  6. Which statement about the zoster (shingles) vaccine Shingrix is correct regarding immunocompromised adults?

    Answer: Shingrix is a recombinant subunit vaccine and can be given to immunocompromised adults ≥19 years

    Shingrix (RZV) is a non-live recombinant subunit vaccine recommended for immunocompromised adults ≥19 years due to their elevated risk of herpes zoster.

  7. What is the recommended interval between the two doses of Shingrix (RZV)?

    Answer: 2–6 months

    The two doses of Shingrix are given 2–6 months apart (or 1–2 months apart for immunocompromised individuals).